首页> 外文期刊>BJOG: an international journal of obstetrics and gynaecology >The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.
【24h】

The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.

机译:雌二醇对具有真正压力性尿失禁的绝经后妇女阴道胶原蛋白代谢的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine whether oestrogen replacement will produce an improvement in the quantity, or quality, of pelvic collagen in postmenopausal women. DESIGN: A prospective double-blind placebo controlled trial of oestrogen therapy. SETTING: Southmead Hospital, Bristol, UK. POPULATION: Fifty-five postmenopausal women with a urodynamic diagnosis of genuine urinary stress incontinence. METHODS: Randomisation to a six-month, double-blind, placebo-controlled, trial of oestradiol valerate 2mg once daily. A 10mg-30mg periurethral biopsy was taken from the vaginal epithelium before and after treatment. Tissue was analysed for total collagen content, intermolecular cross-links, advanced glycation end-products, collagen type ratios and matrix metalloproteinase (MMP) activity. RESULTS: Forty-nine women completed the trial of whom 26 received oestrogen and 23 received placebo. When compared with placebo, oestrogen treatment resulted in significant decreases in total collagen (P = 0.0054), the mature cross-link HHL (P = 0.0009) and the advanced glycation end-product NFC-1 (P = 0.0009). There was a significant rise in the immature cross-link HLKNL (P = 0.0191). Oestrogen produced a significant increase in MMP-2 expression (Pro MMP-2, P = 0.0017). CONCLUSIONS: Six months treatment with oestrogen has profound effects upon pelvic collagen metabolism, stimulating collagen degradation via increased proteinase activity. While aged collagen is being lost, new collagen is synthesised as witnessed by the increase in the immature cross-links and the decrease in both mature cross-links and advanced glycation end-products. Collagen loss contradicts previous reports; perhaps aged collagen degradation is merely an early response to oestrogen stimulation. We have evidence of new collagen synthesis, and it may be that a longer treatment interval would show total collagen content increasing. Further studies within this field are warranted.
机译:目的:确定替代雌激素是否会改善绝经后妇女的骨盆胶原蛋白的数量或质量。设计:雌激素治疗的前瞻性双盲安慰剂对照试验。地点:英国布里斯托尔南米德医院。人口:55名绝经后妇女,其尿动力学诊断为真正的尿毒症。方法:随机分配至六个月,双盲,安慰剂对照的戊酸雌二醇2mg试验,每天一次。在治疗前后,从阴道上皮取10mg-30mg的尿道周围活检。分析组织的总胶原蛋白含量,分子间交联,高级糖基化终产物,胶原蛋白类型比和基质金属蛋白酶(MMP)活性。结果:49名妇女完成了试验,其中26名接受了雌激素,23名接受了安慰剂。与安慰剂相比,雌激素治疗可显着降低总胶原蛋白(P = 0.0054),成熟的交联HHL(P = 0.0009)和高级糖化终产物NFC-1(P = 0.0009)。未成熟的交联HLKNL显着增加(P = 0.0191)。雌激素使MMP-2表达显着增加(Pro MMP-2,P = 0.0017)。结论:用雌激素治疗六个月对骨盆胶原代谢有深远影响,可通过增加蛋白酶活性刺激胶原降解。当老化的胶原蛋白丢失时,新的胶原蛋白被合成,如未成熟交联的增加以及成熟交联和高级糖基化终产物的减少所证明。胶原蛋白丢失与以前的报道相矛盾;也许老化的胶原蛋白降解仅仅是对雌激素刺激的早期反应。我们有新胶原蛋白合成的证据,可能更长的治疗间隔将显示总胶原蛋白含量增加。有必要在该领域内进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号